Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY: DNA )

10.83 +0.63 (+6.18%)
Official Closing Price Updated: 7:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,194,622
Open 10.31
Bid (Size) 10.61 (2)
Ask (Size) 10.84 (1)
Prev. Close 10.20
Today's Range 9.990 - 10.93
52wk Range 5.260 - 64.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Compass Minerals, Torrid Holdings, Icahn Enterprises, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?
Could this beaten-down stock turn things around in the near future? 
Via The Motley Fool

Performance

YTD
+5.97%
+5.97%
1 Month
+7.44%
+7.44%
3 Month
+21.41%
+21.41%
6 Month
-5.37%
-5.37%
1 Year
-77.99%
-77.99%

More News

Read More
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock
Via The Motley Fool
This 1 AI Stock Could Revolutionize Biotech and Pharma
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?
Via The Motley Fool
Earnings Scheduled For November 12, 2024
Via Benzinga
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings
Via Benzinga
What's Going On With Ginkgo Bioworks Stock This Week?
Via Benzinga
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today
Via The Motley Fool
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why
Via Benzinga
From Promise to Peril: The Downfall of Ginkgo Bioworks
Via Benzinga
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?
Via The Motley Fool
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
DNA Stock Earnings: Ginkgo Bioworks Holdings Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Split
Via InvestorPlace
7 Meme Mania Stocks: Which Are FOMO and Which Are Free Money?
Via InvestorPlace
7 Sorry Biotech Stocks Set to Make Investors Sad
Via InvestorPlace
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
DNA Stock: Ginkgo Bioworks Announces New Collaboration
Via InvestorPlace
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?
Via The Motley Fool
3 Stocks to Avoid Like the Plague in 2024
Via InvestorPlace
3 High-Risk, Sky-High Reward Stocks to Buy for Under $1
Via InvestorPlace
Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted
Via InvestorPlace
7 F-Rated Stocks To Sell in July
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.